Summary Judgment Reversed in Favor of Global Med Technologies(R), Inc.
January 04 2007 - 2:03PM
PR Newswire (US)
Disputed Issues of Fact Established in California Appellate Court
DENVER, Jan. 4 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , announced
today that the California Court of Appeal has filed an opinion
regarding the lawsuit against Donnie L. Jackson (Global Med
Technologies, Inc. et al. v. Jackson). In the opinion, the previous
summary judgment and award of attorney fees and costs to Donnie L.
Jackson are reversed and the matter is remanded to trial court.
Unless Jackson persuades the same appellate panel to rehear the
case or persuades the California Supreme Court to review it, the
case will be remanded for trial as directed in the opinion. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global
Med Technologies, Inc. believes that the Appellate Court's opinion
may result in the return of the $1.004 million deposit the Company
made on September 1, 2005 with the Superior Court in the State of
California. The Company is eager to proceed to trial and present
the facts. The Company has not yet determined the materiality of
the financial statement impact of the Appellate Court's opinion,
but believes it may strengthen the Company's financial position.
About Global Med Technologies, Inc. Global Med Technologies, Inc.
is an international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the SafeTrace Tx*(R) advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc. +1-303-238-2000 Web site: http://www.globalmedtech.com/
Copyright